在患有未知原因出血乱的患者中进行血生成分析
Dino Mehic1, Stéphanie E Reitsma2, Claire de Moreuil1,3,4
1Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Blood advances
|September 4, 2024
概括
与健康个体相比,患有原因不明的出血障碍 (BDUC) 的患者表现出降低的峰值等离子体生成和改变的凝块结构. 这些发现表明凝块异常与BDUC之间的潜在联系,有助于诊断.
科学领域:
- 血液学 血液学 血液学
- 血液静止和血栓形成
背景情况:
- 原因不明的出血障碍 (BDUC) 是在排除其他凝血和血小板疾病后诊断出来的.
- 了解BDUC的潜在机制对于改善诊断和管理至关重要.
研究的目的:
- 与健康对照组相比,研究BDUC患者的等离子体生成 (PG) 和凝块特征.
- 为了确定区分BDUC患者的潜在生物标志物.
主要方法:
- 病例控制研究涉及375名BDUC患者和100名健康对照 (HCs).
- 使用校准光检测对PG参数进行分析.
- 通过度测量和共聚焦显微镜评估血凝块的形成,溶解和结构.
主要成果:
- BDUC患者表现出较低的PG速度和峰值等离子体水平,但比HCs具有更高的内源性等离子体潜力.
- 高峰等离子素水平与凝块吸收率 (凝块纤维密度) 相相关,在BDUC患者中观察到更厚的纤维.
- 结合纤维素和PG参数的预测模型在区分BDUC患者和HC患者方面表现出高准确性 (AUC为0.847-0.856).
结论:
- 患有BDUC的患者表现出反直觉地降低了峰值等离子素水平,可能与凝块结构的改变有关.
- 纤维素和PG参数为BDUC提供了重要的诊断潜力.
相关概念视频
01:24Disorders of Hemostasis
754
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
754
01:22Formation of the Platelet Plug
5.3K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
5.3K
01:16Clot Retraction and Fibrinolysis
4.9K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
4.9K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
654
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
654
01:05Introduction to Hemostasis
6.7K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
6.7K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
6.5K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
6.5K